SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-000295
Filing Date
2012-01-04
Accepted
2012-01-03 18:47:20
Documents
13
Period of Report
2012-01-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v244509_8k.htm 8-K 24407
2 EXHIBIT 99.1 v244509_ex99-1.htm EX-99.1 1798
3 GRAPHIC v244509_ex99-1x10x1.jpg GRAPHIC 241047
4 GRAPHIC v244509_ex99-1x11x1.jpg GRAPHIC 364955
5 GRAPHIC v244509_ex99-1x1x1.jpg GRAPHIC 203395
6 GRAPHIC v244509_ex99-1x2x1.jpg GRAPHIC 127437
7 GRAPHIC v244509_ex99-1x3x1.jpg GRAPHIC 222574
8 GRAPHIC v244509_ex99-1x4x1.jpg GRAPHIC 254912
9 GRAPHIC v244509_ex99-1x5x1.jpg GRAPHIC 251550
10 GRAPHIC v244509_ex99-1x6x1.jpg GRAPHIC 195352
11 GRAPHIC v244509_ex99-1x7x1.jpg GRAPHIC 243324
12 GRAPHIC v244509_ex99-1x8x1.jpg GRAPHIC 158873
13 GRAPHIC v244509_ex99-1x9x1.jpg GRAPHIC 187180
  Complete submission text file 0001144204-12-000295.txt   3405513
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21617 | Film No.: 12503478
SIC: 2834 Pharmaceutical Preparations